Despite global dealmaking slowdowns, firms are still on the hunt to find deals and sometimes that means expanding into new areas. This time, one of the heavy hitters in the space is looking to do just that as J.P. Morgan is diving head first into life sciences.
To read the entire story, you must be logged in.
Please log in now or register with us.
